KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

In the ever-evolving healthcare landscape, DNA stands out as a nationwide leader in the nephrology space through its value-based care model. Faced with challenges in the traditional fee-for-service ...

Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

Diabetes-related kidney disease is a rapidly growing crisis in India, affecting millions of individuals and placing a ...

Vindhya Data Science ("Vindhya" or the "Company"), a women-owned leading bioinformatics service provider announced publication of three research reports pertaining to associations between dental/oral ...

Small, gradual lifestyle changes like increasing aerobic exercise, losing weight and eating a healthy diet can reduce your ...

November is National Diabetes Awareness Month and a recent survey by Episcopal Health Foundation shows that nearly half of ...

November is national diabetes awareness month, a time to raise awareness about diabetes and its impact on millions of people ...

This extensive research effort represented one of the largest genetic studies focused on kidney disease in African ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

A breakthrough study reveals that SGLT2 inhibitors, originally for diabetes control, can also improve kidney oxygenation and ...

Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention.